| Utility: Peptides for use in immunotherapy against cancers Filling date: 9 Sep 2025 Issue date: 4 Jan 2022 | 15 May 2019 | 4 Jan 2022 |
| Utility: Immunotherapy against several tumors including neuronal and brain tumors Filling date: 9 Sep 2025 Issue date: 28 Dec 2021 | 23 Jul 2021 | 28 Dec 2021 |
| Utility: Peptides for use in immunotherapy against cancers Filling date: 9 Sep 2025 Issue date: 28 Dec 2021 | 25 Jun 2021 | 28 Dec 2021 |
| Utility: B*44 restricted peptides for use in immunotherapy against cancers and related methods Filling date: 9 Sep 2025 Issue date: 28 Dec 2021 | 30 Jun 2020 | 28 Dec 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 14 Dec 2021 | 13 Apr 2021 | 14 Dec 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 23 Nov 2021 | 13 Apr 2021 | 23 Nov 2021 |
| Utility: Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers Filling date: 9 Sep 2025 Issue date: 23 Nov 2021 | 29 Jun 2020 | 23 Nov 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers Filling date: 9 Sep 2025 Issue date: 9 Nov 2021 | 12 Apr 2021 | 9 Nov 2021 |
| Utility: Immunotherapy against several tumors, such as lung cancer, including NSCLC Filling date: 9 Sep 2025 Issue date: 2 Nov 2021 | 11 Oct 2019 | 2 Nov 2021 |
| Utility: Immunotherapy against several tumors, such as lung cancer, including NSCLC Filling date: 9 Sep 2025 Issue date: 2 Nov 2021 | 11 Oct 2019 | 2 Nov 2021 |
| Utility: Immunotherapy against several tumors including lung cancer Filling date: 9 Sep 2025 Issue date: 2 Nov 2021 | 11 Oct 2019 | 2 Nov 2021 |
| Utility: Immunotherapy against several tumors including lung cancer Filling date: 9 Sep 2025 Issue date: 2 Nov 2021 | 11 Oct 2019 | 2 Nov 2021 |
| Utility: B*44 restricted peptides for use in immunotherapy against cancers and related methods Filling date: 9 Sep 2025 Issue date: 26 Oct 2021 | 7 May 2021 | 26 Oct 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 26 Oct 2021 | 15 Jan 2021 | 26 Oct 2021 |
| Utility: Relaxin1 derived peptides for use in immunotherapy Filling date: 9 Sep 2025 Issue date: 26 Oct 2021 | 12 Nov 2019 | 26 Oct 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 19 Oct 2021 | 22 Jan 2021 | 19 Oct 2021 |
| Utility: Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods Filling date: 9 Sep 2025 Issue date: 12 Oct 2021 | 13 Apr 2021 | 12 Oct 2021 |
| Utility: Peptides and combination of peptides of non- canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 12 Oct 2021 | 15 Jan 2021 | 12 Oct 2021 |
| Utility: Immunotherapy against several tumors including neuronal and brain tumors Filling date: 9 Sep 2025 Issue date: 5 Oct 2021 | 23 Apr 2021 | 5 Oct 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers Filling date: 9 Sep 2025 Issue date: 5 Oct 2021 | 21 Feb 2020 | 5 Oct 2021 |
| Utility: Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers Filling date: 9 Sep 2025 Issue date: 21 Sep 2021 | 13 Apr 2021 | 21 Sep 2021 |
| Utility: B*44 restricted peptides for use in immunotherapy against cancers and related methods Filling date: 9 Sep 2025 Issue date: 14 Sep 2021 | 13 Apr 2021 | 14 Sep 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers Filling date: 9 Sep 2025 Issue date: 14 Sep 2021 | 13 Apr 2021 | 14 Sep 2021 |
| Utility: Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers Filling date: 9 Sep 2025 Issue date: 14 Sep 2021 | 10 Mar 2020 | 14 Sep 2021 |
| Utility: B*44 restricted peptides for use in immunotherapy against cancers and related methods Filling date: 9 Sep 2025 Issue date: 7 Sep 2021 | 30 Jun 2020 | 7 Sep 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers Filling date: 9 Sep 2025 Issue date: 7 Sep 2021 | 17 Apr 2020 | 7 Sep 2021 |
| Utility: T cell receptors and immune therapy using the same Filling date: 9 Sep 2025 Issue date: 7 Sep 2021 | 3 Jan 2020 | 7 Sep 2021 |
| Utility: T cell receptors and immune therapy using the same against PRAME positive cancers Filling date: 9 Sep 2025 Issue date: 7 Sep 2021 | 31 Dec 2019 | 7 Sep 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 31 Aug 2021 | 16 Dec 2020 | 31 Aug 2021 |
| Utility: Peptides and combination thereof for use in the immunotherapy against cancers Filling date: 9 Sep 2025 Issue date: 31 Aug 2021 | 30 Jun 2020 | 31 Aug 2021 |
| Utility: Method for preparing electrocompetent yeast cells, and method for using said cells Filling date: 9 Sep 2025 Issue date: 31 Aug 2021 | 8 May 2020 | 31 Aug 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against CLL and other cancers Filling date: 9 Sep 2025 Issue date: 10 Aug 2021 | 3 Aug 2018 | 10 Aug 2021 |
| Utility: Immunotherapy against several tumors including gastrointestinal and gastric cancer Filling date: 9 Sep 2025 Issue date: 3 Aug 2021 | 28 Jan 2021 | 3 Aug 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers Filling date: 9 Sep 2025 Issue date: 3 Aug 2021 | 10 Dec 2020 | 3 Aug 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 3 Aug 2021 | 5 Apr 2019 | 3 Aug 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers Filling date: 9 Sep 2025 Issue date: 27 Jul 2021 | 15 Jan 2021 | 27 Jul 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers Filling date: 9 Sep 2025 Issue date: 27 Jul 2021 | 9 Dec 2020 | 27 Jul 2021 |
| Utility: T cell receptors with improved pairing Filling date: 9 Sep 2025 Issue date: 27 Jul 2021 | 6 Dec 2017 | 27 Jul 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 20 Jul 2021 | 13 Nov 2020 | 20 Jul 2021 |
| Utility: Peptides and T cells for use in immunother[[r]]apeutic treatment of various cancers Filling date: 9 Sep 2025 Issue date: 20 Jul 2021 | 10 Sep 2020 | 20 Jul 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers Filling date: 9 Sep 2025 Issue date: 20 Jul 2021 | 10 Sep 2020 | 20 Jul 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers Filling date: 9 Sep 2025 Issue date: 20 Jul 2021 | 1 May 2020 | 20 Jul 2021 |
| Utility: A*03 restricted peptides for use in immunotherapy against cancers and related methods Filling date: 9 Sep 2025 Issue date: 13 Jul 2021 | 14 Jan 2021 | 13 Jul 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 13 Jul 2021 | 10 Dec 2020 | 13 Jul 2021 |
| Utility: Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers Filling date: 9 Sep 2025 Issue date: 13 Jul 2021 | 21 Oct 2020 | 13 Jul 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers Filling date: 9 Sep 2025 Issue date: 13 Jul 2021 | 29 Jun 2020 | 13 Jul 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 6 Jul 2021 | 13 Nov 2020 | 6 Jul 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 6 Jul 2021 | 4 Nov 2020 | 6 Jul 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers Filling date: 9 Sep 2025 Issue date: 6 Jul 2021 | 20 Aug 2020 | 6 Jul 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 22 Jun 2021 | 4 Nov 2020 | 22 Jun 2021 |
